Barclays PLC Avrobio, Inc. Transaction History

Barclays PLC

  • $377 Billion
  • Q3 2024

Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 07, 2023
SELL
$0.98 - $1.62 $4,775 - $7,894
-4,873 Reduced 21.97%
17,306 $27,000
Q2 2023

Aug 03, 2023
BUY
$0.58 - $1.31 $141 - $319
244 Added 1.11%
22,179 $21,000
Q2 2022

Aug 12, 2022
SELL
$0.75 - $1.33 $29,502 - $52,316
-39,336 Reduced 64.2%
21,935 $20,000
Q1 2022

May 16, 2022
SELL
$1.29 - $4.04 $51,387 - $160,933
-39,835 Reduced 39.4%
61,271 $81,000
Q4 2021

Feb 14, 2022
BUY
$3.45 - $6.05 $153,024 - $268,347
44,355 Added 78.16%
101,106 $389,000
Q3 2021

Nov 09, 2021
BUY
$5.53 - $9.28 $104,240 - $174,928
18,850 Added 49.73%
56,751 $316,000
Q2 2021

Aug 13, 2021
SELL
$7.84 - $12.6 $224,906 - $361,456
-28,687 Reduced 43.08%
37,901 $337,000
Q1 2021

May 13, 2021
BUY
$10.54 - $19.3 $264,185 - $483,754
25,065 Added 60.36%
66,588 $845,000
Q4 2020

Feb 11, 2021
BUY
$12.79 - $17.1 $304,568 - $407,202
23,813 Added 134.46%
41,523 $579,000
Q3 2020

Nov 12, 2020
SELL
$12.99 - $19.41 $40,126 - $59,957
-3,089 Reduced 14.85%
17,710 $230,000
Q2 2020

Aug 12, 2020
BUY
$12.19 - $22.96 $102,322 - $192,726
8,394 Added 67.67%
20,799 $362,000
Q1 2020

May 13, 2020
SELL
$10.08 - $27.21 $103,440 - $279,229
-10,262 Reduced 45.27%
12,405 $193,000
Q4 2019

Feb 10, 2020
BUY
$13.05 - $21.88 $138,016 - $231,402
10,576 Added 87.47%
22,667 $456,000
Q3 2019

Nov 14, 2019
SELL
$14.12 - $23.44 $24,060 - $39,941
-1,704 Reduced 12.35%
12,091 $171,000
Q2 2019

Aug 14, 2019
BUY
$13.21 - $27.29 $79,048 - $163,303
5,984 Added 76.61%
13,795 $224,000
Q1 2019

May 15, 2019
BUY
$12.46 - $22.05 $59,745 - $105,729
4,795 Added 158.99%
7,811 $172,000
Q4 2018

Feb 14, 2019
SELL
$15.43 - $32.7 $7,421 - $15,728
-481 Reduced 13.75%
3,016 $50,000
Q3 2018

Nov 14, 2018
SELL
$26.95 - $52.7 $357,788 - $699,645
-13,276 Reduced 79.15%
3,497 $181,000
Q2 2018

Aug 14, 2018
BUY
$28.08 - $31.2 $470,985 - $523,317
16,773 New
16,773 $479,000

Others Institutions Holding AVRO

# of Institutions
1
Shares Held
559K
Call Options Held
0
Put Options Held
0
View Full List

About AVROBIO, Inc.

AVRO Quotes by TradingView
  • Ticker AVRO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 43,773,900
  • Description
  • AVROBIO, Inc., a clinical-stage gene therapy company, develops ex vivo lentiviral-based gene therapies to treat rare diseases following a single dose worldwide. Its gene therapies employ hematopoietic stem cells that are collected from patients and modified with a lentiviral vector to insert functional copies of the gene that is defective in the...
More about AVRO
Track This Portfolio

Track Barclays PLC Portfolio

Follow Barclays PLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Barclays PLC, based on Form 13F filings with the SEC.

News

Stay updated on Barclays PLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email